Ctbp2 regulates E-cadherin
Evidence from:
primary |
all sources
Evidence (5 sources)
CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelial-mesenchymal transition in hepatocellular carcinoma.
(2015)
PMID:25686837
cited
these transcriptional repressors target and suppress the expression of multiple tumor repressors, including E-cadherin.
confidence: 0.94
CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelial-mesenchymal transition in hepatocellular carcinoma.
(2015)
PMID:25686837
cited
CtBP2 is recruited to the E-cadherin promoter and modulates its transcription.
confidence: 0.95
CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelial-mesenchymal transition in hepatocellular carcinoma.
(2015)
PMID:25686837
cited
elevated CtBP2 expression attenuated E-cadherin expression
confidence: 0.95
CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelial-mesenchymal transition in hepatocellular carcinoma.
(2015)
PMID:25686837
cited
CtBP2 suppression lead to E-cadherin upregulation in MHCC97 cells
confidence: 0.95
CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelial-mesenchymal transition in hepatocellular carcinoma.
(2015)
PMID:25686837
cited
CtBP2 overexpression did not affect the expression of E-cadherin ... as much as it did in cells expressing normal levels of SNAI1
confidence: 0.60